biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > BiOasis Vs Annexon!

<< Previous

Bullboard Posts

Next >>

Post by narmacon Sep 15, 2022 7:38am

241 Views

Post# 34963753

BiOasis Vs Annexon!

Just tried to do a comparison between the two yesterday. I really think ANNX is well ahead of BTI in progress as they are in the clinic from what I can gather with Pll data and more coming. I will assume when DrDR made the comparison she was pointing out where we could be in a years time or there about. If you brainy investors would have a lookie at the ANNX presentation on their web site and comment.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments